Biovail Pharmaceuticals, Inc., Santhera Pharmaceuticals AG Strike Parkinson's Drug Deal; Santhera Could Pay up to $184 Million
8/24/2009 6:32:40 AM
More...
|
Biovail Pharmaceuticals, Inc. Cuts Dividend 76 Percent as Profit Shrinks
5/6/2009 7:13:40 AM
More...
|
Biovail Pharmaceuticals, Inc. Launches Ralivia(TM) to Canadian Physicians
11/1/2007 12:40:36 PM
More...
|
Biovail Pharmaceuticals, Inc. To Present At The UBS Warburg Global Specialty Pharmaceuticals Conference
4/21/2006 12:44:06 PM
More...
|
Flamel Technologies (FLML) Announces Termination Of Licensing Agreement With Biovail Laboratories Inc. For Genvir And Recovery Of Rights
10/19/2005 5:12:55 PM
More...
|
Biovail (BVF) Launches Tiazac XC To Canadian Physicians
10/19/2005 5:12:33 PM
More...
|
Biovail (BVF) Confirms Receipt Of Notification Of ANDA Submission For Wellbutrin XL; BVF Stock Down
10/19/2005 5:12:14 PM
More...
|
Webcast Alert: Biovail (BVF) Presentation At Informed Investors International Pharmaceuticals Virtual Forum To Be Webcast On Tuesday, November 9, 2004, 3:30 PM ET
10/19/2005 5:12:08 PM
More...
|
Biovail (BVF) Eyes Splitting Chairman, CEO Roles
10/19/2005 5:11:07 PM
More...
|
Biovail (BVF) Announces First Quarter 2004 Earnings Release Conference Call Details
10/19/2005 5:11:00 PM
More...
|
|